IPO Buzz: Hyperliquid Strategies’ $1B Filing Sparks 15% HYPE Rally

Hyperliquid Strategies Inc. (HSI), formed from an $888 cardinal reverse merger betwixt Sonnet Biotherapeutics Holdings Inc. and Rorschach I LLC, has filed a Form S-1 registration with the U.S. Securities and Exchange Commission (SEC) to rise up to $1 cardinal done an offering of 160 cardinal shares of communal stock. Hyperliquid Strategies Files $1B IPO, […]